Evolus, An AbbVie And Botox Rival, Just Hit The Stratosphere — Here's Why
Shares of Evolus made a doubly bullish move Tuesday on a strong preliminary fourth-quarter report and guidance for 2025. The post Evolus, An AbbVie And Botox Rival, Just Hit The Stratosphere — Here's Why appeared first on Investor's Business Daily.
Shares of Evolus made a doubly bullish move Tuesday on a strong preliminary fourth-quarter report and guidance for 2025.
The post Evolus, An AbbVie And Botox Rival, Just Hit The Stratosphere — Here's Why appeared first on Investor's Business Daily.
iShook Opinion
"iShook Opinion" by Beni E Rachmanov, CEO & Founder of iShook. Explore captivating perspectives on entertainment, lifestyle, and sports at ishookdaily.com. Your go-to for engaging insights.
